Kineesiotaping for Patients With LCPD
- Conditions
- Legg-Calve-Perthes Disease
- Interventions
- Other: KinesiotapingOther: Sham taping
- Registration Number
- NCT05840146
- Lead Sponsor
- Istanbul University - Cerrahpasa (IUC)
- Brief Summary
Kinesiotaping is increasingly being used as a complement to musculoskeletal pain management. This study aimed to evaluate the immediate clinical efficacy of kinesiotaping on pain and pain-related symptoms of Legg-Calvé-Perthes Disease (LCPD).
- Detailed Description
Kinesio taping is increasingly being used as a complement to musculoskeletal pain management. A randomized, double-blind, placebo-controlled clinical trial was conducted. Activity-related hip pain, passive and pain limited hip range of motion, gluteus medius muscle strength, function and balance were assessed.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
- Having received unilateral LCPD diagnosis,
- Anterior hip pain minimum three points on 10-cm Visual Analog Scale (VAS) over the previous week,
- Having the following symptoms; weakness of gluteus medius muscle and patient-reported complaints on function or balance
- Having a history of any other hip pathologies,
- Having allergy to polyacrylate adhesive,
- Having used analgesic medication within the previous three days.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Kinesiotaping group Kinesiotaping Kinesiotape was applied to the lateral side of the affected hip for gluteus medius muscle. Each patient was positioned lying down with the affected side up, and two I-strips were used. Sham taping group Sham taping Sham tape was applied with a single I-strip without tension in tape or muscle stretch. After paper backing was completely removed, tape was essentially placed on the skin across the lateral side of the affected hip.
- Primary Outcome Measures
Name Time Method Immediate Clinical Efficacy on Activity Related Hip The change between T1 (baseline) to T2 (thirty minutes later from the application) Horizontal 10 cm VAS (0, no pain; 10, the worst pain ever possible)
- Secondary Outcome Measures
Name Time Method Immediate Clinical Efficacy on Functional Task Durations The change between T1 (baseline) to T2 (thirty minutes later from the application) 10-meters walk task duration (sec) and 10-step climbing task duration (sec)
Immediate Clinical Efficacy on Gluteus medius muscle strength The change between T1 (baseline) to T2 (thirty minutes later from the application) muscle strength by handheld dynamometer (Ibs)
Immediate Clinical Efficacy on Balance test durations The change between T1 (baseline) to T2 (thirty minutes later from the application) One leg stance test duration (sec) and Tandem walk test duration (sec)
Immediate Clinical Efficacy on Hip Abduction ROM The change between T1 (baseline) to T2 (thirty minutes later from the application) goniometric range of motion (ROM)
Trial Locations
- Locations (1)
Istanbul University-Cerrahpasa
🇹🇷Istanbul, Turkey